longevitywatch
← All podcasts

Bryan Johnson

hosted by Bryan Johnson

We tested 11 claims from Bryan Johnson against the research. 1 held up, 1 did not, and the rest are partly true or still too early to judge.

We only test the claims that can be checked, not everything that is said. This is not a ranking.

Bryan Johnson · hosts Bryan Johnson

American tech entrepreneur and biohacker behind the Blueprint project

Partly
“A single dose of psilocybin can provide long-lasting psychological benefits and reduce inflammation”
Bryan Johnson (American tech entrepreneur and biohacker behind the Blueprint project) · Bryan Johnson, October 2026 · watch the episode ↗︎ · stated with caution
In guided settings, psilocybin shows positive signals in terms of mood and brain function, but the studies are still small and often lack a proper control group, which means "long-lasting psychological benefits" goes beyond what the current evidence firmly supports. The inflammation claim stands on even shakier ground: whether psilocybin reduces inflammation in humans has not yet been demonstrated, and the early clinical trials investigating this have not yet published their results. The claim thus combines a cautiously supported effect with one for which human evidence is currently lacking.
✗ Does not hold up
“The pace of biological ageing can be slowed to six months per twelve calendar months.”
Bryan Johnson (American tech entrepreneur and biohacker) · Bryan Johnson, November 2026 · watch the episode ↗︎ · shared as personal experience
Biological age is measurable and is associated with health risks, but evidence that the pace of biological ageing can be deliberately influenced is currently lacking; let alone that this pace can be reduced to a specific ratio such as six months per twelve calendar months. No study with solid clinical support has shown that such a precise deceleration is achievable; the available studies are small and methodologically immature. The claim therefore goes considerably beyond what research has demonstrated so far.
Too early
“Magic mushrooms may work as a therapy against ageing by influencing biological systems that drive ageing”
Bryan Johnson (American tech entrepreneur and biohacker behind the Blueprint project) · Bryan Johnson, October 2026 · watch the episode ↗︎ · stated with caution
Research shows that psilocybin extends the lifespan of cells and improves the survival of old mice, and that this effect is linked to processes that play a role in ageing. That is promising, but so far it is based solely on cell research and animal studies. In humans, three clinical trials have been registered, but they are still ongoing and have not yet published results. Whether psilocybin also works as a therapy against ageing in humans has therefore not yet been demonstrated. The claim thus goes further than what current research supports.
Partly
“Ageing is associated with rigid neural patterns in the brain”
Bryan Johnson (American tech entrepreneur and biohacker behind the Blueprint project) · Bryan Johnson, October 2026 · watch the episode ↗︎ · stated with confidence
Research in humans does indeed show that the brain changes with age: the plasticity of brain regions such as the prefrontal cortex and the medial temporal lobe decreases, and dopamine regulation of cognitive flexibility shifts in older adults. Older rats also show an overactive pattern in part of the hippocampus that leads to rigid memory representations. However, the picture is more nuanced than the claim suggests: in humans, the brain also appears to deploy compensatory strategies (such as increased frontal activation), and language networks remain largely stable. One large study involving 386 people found no association at all between age and neural flexibility. The claim that ageing simply goes hand in hand with rigid neural patterns is therefore only partially correct. → Does your brain become less flexible as you age?
Partly
“Chronic inflammation accelerates biological ageing and is strongly associated with cardiovascular disease, premature death and insulin resistance”
Bryan Johnson (American tech entrepreneur and biohacker behind the Blueprint project) · Bryan Johnson, October 2026 · watch the episode ↗︎ · stated with confidence
Chronic inflammation demonstrably accelerates biological ageing, and the association with insulin resistance is consistent enough to take seriously. The link with cardiovascular disease is also well supported: higher inflammatory markers go hand in hand with a measurably greater risk of serious cardiovascular problems. Nevertheless, the evidence does not go so far as to speak of a strongly demonstrated causal relationship, since most studies are observational and, for specific outcomes such as premature death, direct causality has not yet been conclusively proven. The word "strongly" in the claim therefore goes somewhat further than current research allows.
Partly
“Optimism is associated with a 35 percent lower risk of a heart attack”
Bryan Johnson (American tech entrepreneur and biohacker behind the Blueprint project) · Bryan Johnson, October 2026 · watch the episode ↗︎ · stated with confidence
That optimism is associated with a lower risk of heart problems is confirmed by several large, long-running studies, and the pattern is strikingly consistent. However, the precise figure of 35 percent cannot be substantiated on the basis of the available research. Moreover, these are associations, not proven cause and effect: being more optimistic does not automatically protect your heart, and other factors may play a role.

Amir Moarefi

ophthalmologist

Partly
“Photobiomodulation with specific wavelengths of light stimulates eye cells and can slow the degeneration of eye tissue.”
Amir Moarefi (ophthalmologist) · Bryan Johnson, November 2026 · watch the episode ↗︎ · stated with confidence
Several randomised controlled trials show that photobiomodulation with specific wavelengths (590, 660 and 850 nm) can improve visual acuity and slow signs of disease progression in people with dry macular degeneration. The claim is therefore broadly correct. Nevertheless, a meta-analysis combining three of these studies raises an important caveat: the groups studied were small, the risk of bias was high in all studies, and the measurable improvements were in practice not large enough to make a real difference for patients. Furthermore, several studies were funded by the manufacturer of the device used, which affects the reliability of the results. The claim that photobiomodulation "can slow degeneration" is therefore plausible, but not yet proven firmly enough to state without reservation.
Partly
“Omega-3 fatty acids and lutein support tear quality and help protect the retina.”
Amir Moarefi (ophthalmologist) · Bryan Johnson, November 2026 · watch the episode ↗︎ · stated with confidence
On omega-3 and tear quality: a review of seven human studies shows that omega-3 supplements improve tear film stability and tear volume, but that patients' symptoms do not clearly diminish noticeably. Another review of studies on meibomian gland disorders finds mixed effects of omega-3 and concludes that more research is needed. On lutein and retinal protection: several large human studies show that lutein and zeaxanthin can slow the progression of age-related macular degeneration, and that these substances are a good substitute for beta-carotene. The claim is therefore broadly correct on both points, but the evidence for omega-3 and tear quality is less strong than the evidence for lutein and the retina. The studies provide no support for a protective effect of omega-3 on the retina. → How do I keep my eyes healthy and prevent cataracts or macular degeneration?

Kate Tolo

Chief Marketing Officer and project participant at Blueprint

✓ Holds up
“Women, just like men, go through physiological arousal cycles every night during sleep.”
Kate Tolo (Chief Marketing Officer and project participant at Blueprint) · Bryan Johnson, August 2026 · watch the episode ↗︎ · stated with confidence
This is correct and less widely known than its male equivalent. During REM sleep, women experience increased blood flow to the genitals in the same cycles as men, several times per night. This has been established through measurements in sleep laboratories.
Partly
“Women experience significant biological changes and fluctuations every month, at every stage of life, and in virtually every organ system.”
Kate Tolo (Chief Marketing Officer and project participant at Blueprint) · Bryan Johnson, August 2026 · watch the episode ↗︎ · stated with confidence
It is fair to say that the menstrual cycle affects far more than reproduction alone, and it is also true that women were long underrepresented in research. However, 'virtually every organ system' is a stronger claim than what has actually been measured: there is clear evidence for effects on sleep, mood, body temperature and immune responses, but for many other organs the question simply has not been studied. The point is valid, but its scope has been overstated.

Ed Streit

Elite strength coach and trainer

Partly
“A VO2 max in the 50s (ml/kg/min) corresponds to the capacity of a supremely fit 18-year-old.”
Ed Streit (Elite strength coach and trainer) · Bryan Johnson, September 2026 · watch the episode ↗︎ · stated with caution
Reference data for VO2 max show that the median for men aged 20 to 29 is around 48 ml/kg/min, which is close to the "50 range" mentioned. For women in that age group, however, the median is considerably lower, at around 37 to 38 ml/kg/min. The claim refers to 18-year-olds, but the major reference databases start at age 20, so separate reference values for 18-year-olds within adult standards are lacking. Moreover, what counts as "supremely fit" varies greatly by sex, and a value of 50 ml/kg/min is for men in that age group more average to slightly above average than characteristic of a "supremely fit" 18-year-old. → What is VO2max and how important is it for living longer?
Newsletter

Stay in the loop

Every Thursday, the most important longevity research in your inbox, focused on what you follow.